NCT06559163Phase 2Active not recruiting

A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

Study sponsor: Zenas BioPharma (USA), LLC

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-09-23Actual
Enrollment · participants190Actual
Source updated2026-11-17Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Sep 2026. After: 23 Sep 2026.

Check registry source

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Jun 2026. After: Sep 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview